Allergy Diagnostics Market Archives

Expanding cases of allergic diseases (asthma, allergic rhinitis, atopic dermatitis, and food allergy), rising environmental pollution levels, high volume consumption of processed foods and beverages, the introduction of mHealth in allergy diagnosis and care, and rising awareness about allergic diseases are among the key factors driving the Global Allergy Diagnostics Market. Allergies are body’s reaction to a substance it considers as a harmful “invader.” Substances that cause these reactions are called allergens. An individual can be allergic to a wide variety of substances including pollen, food and drug, animal dander, molds, insect venom, latex, dust mites, among others. Allergic diseases are a global health problem that affects approximately 20-30% of the population in industrialized countries. The prevalence of allergic diseases globally has continued to grow in the industrialized world for more than 50 years. Allergic diseases such as allergic asthma, allergic rhinitis, atopic dermatitis, anaphylaxis, and food and drug allergies are complex and cause a broad spectrum of symptoms ranging from mild to severe and potentially life-threatening anaphylactic reactions. According to The Asthma and Allergy Foundation of America (AAFA), allergies are the 6th leading cause of chronic illness in the U.S. and each year more than 50 million Americans experience various types of allergies. Continuously rising cases of allergic diseases and other related medical conditions has fueled the global allergy diagnostics market. Find A Free Sample of Our Research Report : https://meditechinsights.com/allergy-diagnostics-market/request-sample/ Growing Prominence of mHealth in Allergy Diagnosis & Allergy Care The widespread availability of technology-based interventions such as mobile health in the clinical setting has enabled patients to play an active role in their medical care. Mobile health (mHealth) utilizes mobile communication devices such as computers, tablets and smartphones to improve patient education & self-management of diseases, help in remote surveillance of patient’s health, flow of data and information and disease management from first diagnosis to an optimized treatment. Advent of patient-facing mHealth technologies (such as apps) is expected to favorably impact clinical, economic and process outcomes. Features such as medication reminders, educational content, games-based self management, symptom diaries, electronic sensors, patient self-tracking dashboards, voice recognition, wearable technology, pollen sensors, and virtual reality offered by apps not only improves patient knowledge but also improves medication adherence, asthma and allergic conditions control, quality of life and results in fewer unscheduled office visits. mHealth offers allergists and patients a new mode of communication via the phone camera, sound recording system, motion sensors, texting, and by using diagnostic devices and diagnostic algorithms incorporated in the smartphone itself. High Volume Consumption of Processed Food and Beverages Set to Spur the Food Allergen Testing Market Food allergens continue to prevail as high-risk factors for the food production industry. The food allergen testing industry has garnered considerable traction globally because of high daily consumption of processed food and beverages. Allergens are a significant cause for concern in the global food processing industry. Food allergies which include abnormal reactions or hypersensitivity produced by the body’s immune system are considered a major food safety challenge. The food allergen testing market is anticipated to witness considerable momentum in the coming years due to growth of the dairy, processed food and confectionary segments. Allergen detection tests are a key feature of allergen management systems in food processing plants and are executed at nearly every step of the process. These tests are carried out on work surfaces and products to detect any cross contamination or allergen presence, and to test the effectiveness of a food processing unit’s cleaning measures. “The global food allergen testing market is expected to witness significant growth in the coming years due to expansion of the dairy, processed food and confectionary segments. Food allergy related cases have risen by ~ 50% in the last decade, with an astounding 700% increase observed in hospitalizations due to anaphylaxis. Food allergies are a growing health concern, with more than 250 million people worldwide estimated to be affected. "This continuously rising prevalence of food allergies opens up an array of opportunities for the food allergen testing industry. By testing for allergens in food products, organizations can precisely mention each ingredient, and thereby allow people with specific food allergies to avoid consuming them." - CEO, Leading Allergy Diagnostics Product Manufacturer, United States Allergy Diagnostics Market: Key Companies Thermo Fisher Scientific Siemens Healthineers Danaher Omega Diagnostics Group PLC NEOGEN Corporation Minaris Medical America, Inc. bioMérieux SA Stallergenes Greer HOB Biotech Group Corp., Ltd. HYCOR Biomedical Lincoln Diagnostics, Inc. EUROIMMUN Medizinische Labordiagnostika AG R-Biopharm AG Astra Biotech GmbH Erba Group Other Players Key Strategic Questions Addressed What is the market size & forecast of Allergy Diagnostics market? What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of Allergy Diagnostics market? What are the key trends defining the Allergy Diagnostics market? What are the major factors impacting the Allergy Diagnostics market? What are the opportunities prevailing in the market? Which region has the highest share in the global market? Which region is expected to witness highest growth rate in the next 5 years? Who are the major players operating in the Allergy Diagnostics market? Who are the new players entering the market? What are the key strategies adopted by players?

Tag: Allergy Diagnostics Market

Global Allergy Diagnostics Market valued at ~$4.9 billion (2021) is set to witness a healthy growth rate of 11% in the next 5 years.

Global Biologics CDMO Market is set to soar at substantial CAGR of 14–16% in the next five years.

Oncology Information System Market Projected to Witness High Growth of 8% from 2024 to 2029

The Transplantation Market Expected to Grow at a 9-10% CAGR by 2029, Fueled by Advancements in Transplant Technologies

The Bioburden Testing Market Maintains Strong CAGR with Growing Demand for Sterilization Assurance

The Fluoroscopy Equipment Market is Poised to grow at a CAGR of 5–7%.

The Bionic Contact Lenses Market is poised to grow at a high CAGR of 11-13%

Global Biosimulation Market Envisions a Promising Future to Have a High 15-20% Growth by 2028

Global Intraocular Lens (IOLs) Market Expecting a Decent 5-6% CAGR in the Next 5 Years

The Cardiology Information System (CIS) Market is projected to grow at a healthy CAGR of 8-10% over the next few years.

Global FemTech Market valued at ~$22 billion (2020) is projected to rise at a healthy growth rate of 15% by 2025.